Lead-time bias in studies of cinacalcet prescriptions

Marie Evans1, Carl Michael Fored

  • 1Division of Renal Medicine, Department of Clinical Science Intervention and Technology, Karolinska University Hospital, Huddinge, Stockholm, Sweden. Marie.Evans@ki.se

Kidney International
|September 1, 2010
PubMed

Insights

Higher serum phosphate, calcium, and parathyroid hormone levels are linked to cardiovascular death. Cinacalcet may improve mortality in hemodialysis patients, but observational study biases require cautious interpretation.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Pharmacology

Background:

  • Elevated serum phosphate, calcium, and parathyroid hormone are associated with cardiovascular mortality.
  • Secondary hyperparathyroidism is common in hemodialysis patients.
  • Cinacalcet is a calcimimetic agent used to treat secondary hyperparathyroidism.

Purpose of the Study:

  • To discuss the potential biases in observational studies examining the effect of cinacalcet on mortality.
  • To highlight the need for cautious interpretation of findings from observational research.

Main Methods:

  • Review of observational studies on cinacalcet and mortality.
  • Discussion of potential confounding factors and biases in observational data.
  • Analysis of the association between cinacalcet, mineral metabolism, and cardiovascular outcomes.

Main Results:

  • Observational data suggest cinacalcet treatment is associated with improved all-cause and cardiovascular mortality in hemodialysis patients.
  • Potential biases, such as confounding by indication and unmeasured confounders, may influence these findings.
  • The observed mortality benefits require careful consideration due to the limitations of observational study designs.

Conclusions:

  • While cinacalcet shows promise in reducing mortality in hemodialysis patients with secondary hyperparathyroidism, observational data must be interpreted with caution.
  • Further investigation using robust study designs is needed to confirm these findings.
  • Understanding and mitigating bias are crucial for accurate assessment of therapeutic interventions.

Related Concept Videos

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...